| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.03 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.066 | 0.03 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.17 | 0.03 |